Bolt Acquisition Deal Drives BSX Stock Close to 52-Week High Boston Scientific stock is currently trading close to its 52-week high. In the past four trading sessions, the stock has consistently ...

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

Boston Scientific Corp. is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

Boston Scientific (BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

Boston Scientific is diving into the field of intravascular lithotripsy, with a $664 million deal to pick up Bolt Medical and ...

Pittcon 2025 in Boston: a landmark event uniting industry and academia to advance analytical chemistry and foster groundbreaking scientific collaboration.

Boston Scientific acquires Bolt Medical for $443 million upfront, with up to $221 million contingent on regulatory milestones. Bolt IVL platform uses acoustic waves to treat calcified artery ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy advanced laser-based platform for the treatment ...

The Marlborough device maker is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder of a company in which it already owned a major stake. Boston ...

Boston Scientific Corp (NYSE:BSX), a $144.82 billion medical device manufacturer with strong financial health according to InvestingPro analysis, has received preliminary court approval for a ...